Demonstration of a model of involvement of APCs in SARS-CoV-2 early dissemination through CRLs DC/L-SIGN, could open new avenues for understanding and treating the imbalanced innate immune response observed in COVID-19 pathogenesis. This evidence concerns the gene CLEC4M and COVID-19.